Application of fusion protein 4D5 scFv-dibarnase:barstar-gold complex for studying P185HER2 receptor distribution in human cancer cells

Biochimie

Volumn 94, Issue 8, 2012, Pages 1833-1836

  Ivanova, Julia L ^a   Edelweiss, Evelina F ^b   Leonova, Olga G ^a   Balandin, Taras G ^b   Popenko, Vladimir I ^a   Deyev, Sergey M ^b,c  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^c PRIVOLZHSKY RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

4D5 scFv; Barnase; Barstar; Immune electron microscopy; P185HER2

Indexed keywords

4D5 SCFV DIBARNASE BARSTAR GOLD FUSION PROTEIN; BARNASE; BARSTAR; CELL RECEPTOR; HYBRID PROTEIN; MONOCLONAL ANTIBODY; P185 HER2 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CARCINOMA CELL; CELL SURFACE; CELL VACUOLE; COATED PIT; COMPLEX FORMATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOSOME; EXTRACELLULAR SPACE; FEMALE; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; MULTIVESICULAR BODY; OVARY CARCINOMA; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

ANTIBODIES, MONOCLONAL; BACTERIAL PROTEINS; BREAST NEOPLASMS; CELL LINE, TUMOR; COATED PITS, CELL-MEMBRANE; COATED VESICLES; ENDOSOMES; FEMALE; GOLD; HUMANS; MULTIVESICULAR BODIES; OVARIAN NEOPLASMS; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; RIBONUCLEASES; STAINING AND LABELING; TEMPERATURE;

BACILLUS AMYLOLIQUEFACIENS;

EID: 84862893347     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.04.011     Document Type: Article

References (17)

1. H. Waterman, Y. Yarden, Molecular mechanisms underlying endocytosis and sorting of Erb receptor tyrosine kinases, FEBS Lett. 490 (2001) 142-152.
2. S. Menard, S.M. Pupa, M. Campiglio, E. Tagliabue, Biologic and therapeutic role of HER2 in cancer, Oncogene 22 (2003) 6570-6578.
3. L.A. Maier, F.J. Xu, S. Hester, C.M. Boyer, S. McKenzie, A.M. Bruskin, Y. Argon, R.C. Bast Jr.2, Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-21, Cancer Res. 51 (1991) 5361-5369.
4. E. Hurwitz, I. Stancovski, M. Sela, Y. Yarden, Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake, Proc. Natl. Acad. Sci. USA 92 (1995) 3353-3357.
5. C.D. Austin, A.M. De Maziere, P.I. Pisacane, S.M. Van Dijk, C. Eigenbrot, M. Sliwkowski, J. Klumperman, R.H. Scheller, Endocytosis and sorting of Erb2 and site of action of cancer therapeutics trastuzumab and geldanamycin, Mol. Biol. Cell 15 (2004) 5268-5282.
6. J.C. Sarup, R.M. Johnson, K.L. King, B.M. Fendly, M.T. Lipari, M.A. Napier, A. Ullrich, H.M. Shepard, Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth, Growth Regul. 1 (1991) 72-82.
7. K. De Santes, D. Slamon, S.K. Anderson, M. Shepard, B. Fendly, D. Maneval, O. Press, Radiolabeled antibody targeting of the HER-2/neu oncoprotein, Cancer Res. 52 (1992) 1916-1923.
8. S.M. Deyev, R. Waibel, E.N. Lebedenko, A.P. Schubiger, A. Plückthun, Design of multivalent complexes using the barnase-barstar module, Nat. Biotechnol. 21 (2003) 1486-1492.
9. S.M. Deyev, E.N. Lebedenko, Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design, Bioessays 30 (2008) 904-918.
10. M.P. Nikitin, T.A. Zdobnova, S.V. Lukash, O.A. Stremovskiy, S.M. Deyev, Protein-assisted self-assembly of multifunctional nanoparticles, Proc. Natl. Acad. Sci. USA 107 (2010) 5827-5832.
11. E.F. Edelweiss, T.G. Balandin, J.L. Ivanova, G.V. Lutsenko, O.G. Leonova, V.I. Popenko, A.M. Sapozhnikov, S.M. Deyev, Barnase as a new therapeutic agent triggering apoptosis in human cancer cells, PLoS One 3 (2008) 2434.
12. S. Yazynin, H. Lange, T. Mokros, S. Deyev, H. Lemke, A new phagemid vector for positive selection of recombinants based on a conditionally lethal barnase gene, FEBS Lett. 452 (1999) 351-354.
13. J.W. Slot, H.J. Geuze, A new method of preparing gold probes for multiple-labeling cytochemistry, Eur. J. Cell Biol. 38 (1985) 87-93.
14. J. Roth, The colloidal gold marker system for light and electron microscopic cytochemistry, in: Techniques in Immunocytochemistry 2, Academic Press, London, 1983, pp. 218-284.
15. B. Becerril, M.A. Poul, J.D. Marks, Toward selection of internalizing antibodies from phage libraries, Biochem. Biophys. Res. Commun. 255 (1999) 386-393.
16. A.M. Hommelgaard, M. Lerdrup, B. van Deurs, Association with membrane protrusions makes ErbB2 an internalization-resistant receptor, Mol. Biol. Cell 15 (2004) 1557-1567.
17. O.L. Polanovski, E.N. Lebedenko, S.M. Deyev, ERBB oncogene proteins as targets for monoclonal antibodies, Biochemistry 77 (2012) 227-245.